<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Characteristics of the study population</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>Eligible</th>
    <th>Participated</th>
    <th>HIV-1 positive</th>
    <th>Reporting no ART use</th>
    <th>Deep-sequenced</th>
    <th>Part of phylogenetically inferred transmission chain</th>
    <th>Highly supported phylogenetic linkage and direction of transmission</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Total</td>
    <td>37,645</td>
    <td>25,882</td>
    <td>5142</td>
    <td>3878</td>
    <td>2652</td>
    <td>1334</td>
    <td>554</td>
   </tr>
   <tr>
    <td>Women</td>
    <td>18,946</td>
    <td>13,791</td>
    <td>3149</td>
    <td>2251</td>
    <td>1447</td>
    <td>686</td>
    <td>279</td>
   </tr>
   <tr>
    <td colspan="8">Age</td>
   </tr>
   <tr>
    <td>    15–24</td>
    <td>9203 (24%)</td>
    <td>5839 (23%)</td>
    <td>718 (14%)</td>
    <td>610 (16%)</td>
    <td>403 (15%)</td>
    <td>210 (16%)</td>
    <td>91 (16%)</td>
   </tr>
   <tr>
    <td>    25–34</td>
    <td>6158 (16%)</td>
    <td>4905 (19%)</td>
    <td>1463 (28%)</td>
    <td>1104 (28%)</td>
    <td>717 (27%)</td>
    <td>356 (27%)</td>
    <td>141 (25%)</td>
   </tr>
   <tr>
    <td>35+</td>
    <td>3585 (10%)</td>
    <td>3047 (12%)</td>
    <td>968 (19%)</td>
    <td>537 (14%)</td>
    <td>327 (12%)</td>
    <td>120 (9%)</td>
    <td>47 (8%)</td>
   </tr>
   <tr>
    <td>Men</td>
    <td>18,699</td>
    <td>12,091</td>
    <td>1993</td>
    <td>1627</td>
    <td>1205</td>
    <td>648</td>
    <td>275</td>
   </tr>
   <tr>
    <td colspan="8">Age</td>
   </tr>
   <tr>
    <td>    15–24</td>
    <td>7907 (21%)</td>
    <td>4845 (19%)</td>
    <td>237 (5%)</td>
    <td>215 (6%)</td>
    <td>163 (6%)</td>
    <td>92 (7%)</td>
    <td>33 (6%)</td>
   </tr>
   <tr>
    <td>    25–34</td>
    <td>6317 (17%)</td>
    <td>4052 (16%)</td>
    <td>929 (18%)</td>
    <td>817 (21%)</td>
    <td>618 (23%)</td>
    <td>351 (26%)</td>
    <td>145 (26%)</td>
   </tr>
   <tr>
    <td>35+</td>
    <td>4475 (12%)</td>
    <td>3194 (12%)</td>
    <td>827 (16%)</td>
    <td>595 (15%)</td>
    <td>424 (16%)</td>
    <td>205 (15%)</td>
    <td>97 (18%)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>ART, antiretroviral therapy</p>
 </table-wrap-foot>
</table-wrap>
